The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
there's a great vaginal preparation for DHEA called inosa and then the receptors there will start converting it into to both testosterone and estradi you know through the process and so um the sexual medicine docs really like in Roa especially for breast cancer patients because they get that little boost of testosterone in the vulva
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
intr Roa is the brand name I think it's prostone and this is a prescription drug yeah these are prescriptions so intr roa's prescription DHEA was specifically formulated for the vagina
that said there is very good data supporting the use of a vaginal intravaginal DHEA the chemical is called prostone the brand is called intr Roa it's um basically it's a it's like a little suppository it's used for vvo vaginal atrophy resulting in genital urinary symptoms of menopause and the indication is disperar pain postmenopause and it has very good efficacy and safety data with very little systemic absorption for that indication
of menopause and the indication is disperar pain postmenopause and it has very good efficacy and safety data with very little systemic absorption for that indication
And the only FDA approved product we have is um intraosa which is vaginal dha.